Business Description
D. Western Therapeutics Institute Inc
ISIN : JP3548740004
Compare
Compare
Traded in other countries / regions
4576.Japan6DW.Germany IPO Date
2013-07-16Description
D. Western Therapeutics Institute Inc is engaged in the research and development of pharmaceutical drugs in Japan. Its products include ophthalmic solution and agents for antiplatelet and anti-glaucoma.
Financial Strength
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 2.11 | |||||
| Equity-to-Asset | 0.54 | |||||
| Debt-to-Equity | 0.69 | |||||
| Debt-to-EBITDA | -1.07 | |||||
| Piotroski F-Score | 1/9 | |||||
| Altman Z-Score | 0.46 | |||||
| Beneish M-Score | -3.3 | |||||
| WACC vs ROIC | ||||||
Growth Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 1 | |||||
| 3-Year EBITDA Growth Rate | -40.2 | |||||
| 3-Year EPS without NRI Growth Rate | -34.7 | |||||
| 3-Year FCF Growth Rate | -32.5 | |||||
| 3-Year Book Growth Rate | -18.6 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 11.23 | |||||
| 9-Day RSI | 15.9 | |||||
| 14-Day RSI | 21.49 | |||||
| 6-1 Month Momentum % | -16.11 | |||||
| 12-1 Month Momentum % | -39.02 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 11.02 | |||||
| Quick Ratio | 10.57 | |||||
| Cash Ratio | 9.62 | |||||
| Days Inventory | 939.56 | |||||
| Days Sales Outstanding | 118.5 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -3.2 | |||||
| Shareholder Yield % | -5.31 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 91.44 | |||||
| Operating Margin % | -186.42 | |||||
| Net Margin % | -189.65 | |||||
| FCF Margin % | -140.48 | |||||
| ROE % | -47.88 | |||||
| ROA % | -29.8 | |||||
| ROIC % | -171.62 | |||||
| ROC (Joel Greenblatt) % | -435.89 | |||||
| ROCE % | -32.45 | |||||
| Years of Profitability over Past 10-Year | 1 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 7.59 | |||||
| PB Ratio | 2.56 | |||||
| Price-to-Tangible-Book | 2.75 | |||||
| EV-to-EBIT | -2.78 | |||||
| EV-to-EBITDA | -2.78 | |||||
| EV-to-Revenue | 5.36 | |||||
| EV-to-FCF | -4.08 | |||||
| Price-to-Median-PS-Value | 0.19 | |||||
| Price-to-Net-Current-Asset-Value | 3.14 | |||||
| Price-to-Net-Cash | 4.24 | |||||
| Earnings Yield (Greenblatt) % | -35.9 | |||||
| FCF Yield % | -18.36 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
D. Western Therapeutics Institute Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil 円) | 428.364 | ||
| EPS (TTM) (円) | -25.56 | ||
| Beta | 0.65 | ||
| Volatility % | 27.57 | ||
| 14-Day RSI | 21.49 | ||
| 14-Day ATR (円) | 3.83071 | ||
| 20-Day SMA (円) | 115.95 | ||
| 12-1 Month Momentum % | -39.02 | ||
| 52-Week Range (円) | 100 - 238 | ||
| Shares Outstanding (Mil) | 32.13 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 1 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
D. Western Therapeutics Institute Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
D. Western Therapeutics Institute Inc Stock Events
| Event | Date | Price(円) | ||
|---|---|---|---|---|
| No Event Data | ||||
D. Western Therapeutics Institute Inc Frequently Asked Questions
What is D. Western Therapeutics Institute Inc(TSE:4576)'s stock price today?
The current price of TSE:4576 is 円102.00. The 52 week high of TSE:4576 is 円238.00 and 52 week low is 円100.00.
When is next earnings date of D. Western Therapeutics Institute Inc(TSE:4576)?
The next earnings date of D. Western Therapeutics Institute Inc(TSE:4576) is .
Does D. Western Therapeutics Institute Inc(TSE:4576) pay dividends? If so, how much?
D. Western Therapeutics Institute Inc(TSE:4576) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers